Elizabeth Wassenaar, MD, MS, CEDS-S, DFAPA

New research reveals ketamine's safe use for treating eating disorders, offering hope for patients with comorbid treatment-resistant depression.

An expert discusses this comorbidity, plus the effects of semaglutide and other GLP-1 agonists on this patient population.